Clinical trial
Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer
NCT00435214 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00435214 |
|---|---|
| Title | Human Papillomavirus (HPV) and Risk of Cervical Precancer and Cancer |
| Official title | The HPV Persistence and Progression (PaP) Cohort at Kaiser Permanente Northern California |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Cervical Neoplasia |
| Enrollment | 131,110 |
| Start date | Jan 29, 2007 |
| Primary completion | Apr 1, 2020 |
| Completion | Apr 30, 2020 |
| First posted | Feb 14, 2007 |
| Last update posted | May 1, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: